This page includes the latest FDA filings for Boehringer Ingelheim Espa A S A. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
---|---|---|
Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Pharma GmbH and Co. KG, Boehringer Ingelheim España, S.A. | Prescription Medication | 2025-01-12 |
Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Pharma GmbH and Co. KG, Boehringer Ingelheim España, S.A. | Prescription Medication | 2023-10-05 |
Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Pharma GmbH and Co. KG, Boehringer Ingelheim España, S.A. | Prescription Medication | 2023-05-25 |
Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Pharma GmbH and Co. KG, Boehringer Ingelheim España, S.A. | Prescription Medication | 2022-01-28 |
Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Pharma GmbH and Co. KG, Boehringer Ingelheim España, S.A. | Prescription Medication | 2020-10-24 |
Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Pharma GmbH and Co. KG, Boehringer Ingelheim España, S.A. | Prescription Medication | 2019-04-25 |
NCAGE Code | 0400B | BOEHRINGER INGELHEIM ESPAÑA SA |
CAGE Code | 1401B | BOEHRINGER INGELHEIM ESPAÑA SA |